NanoZymeX
PrivateLast Round
Pre Seed
Mar 24, 2026
Total Funding Raised
$200,000
Company Overview
NanoZymeX is a nanobiotechnology company developing next-generation enzyme replacement therapies using proprietary lipid-based nanoparticles for rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
enzyme replacement therapyERTlipid nanoparticlesLNP deliverydrug delivery platformnanobiotechnologyrare disease therapylysosomal storage disordersnanomedicinePompe diseaseorphan drugsintracellular deliverydrug out-licensingpreclinical therapyScience-as-a-ServiceSaaS
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoZymeX Comps
Public and private peers based on sector, stage, and business model.
NanoZymeX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 24, 2026 |
NanoZymeX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Kick | Pre Seed |
NanoZymeX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NanoZymeX's valuation, stock price, and market status.
